Table 1 Cytological, histological, and follow-up results, including the serum levels of ovarian cancer tumour markers and the ROMA index (%), for women with ovarian hyperstimulation syndrome
Case no. | Age (y) | Douglas puncture | OIT | Ascites cytology* | Control histology | Remarks | CA-125 (U/mL) | HE4 (pM) | ROMA (%) |
|---|---|---|---|---|---|---|---|---|---|
1 | 28 | 05/2006 | CC + hMG + hCG | P IV | 06/2006, neg.# | Tumor-free | 45.2 | 40.1 | 4.9 |
2 | 23 | 03/2007 | FSH + hMG + hCG | P IV | 05/2007, neg.# | Tumor-free | 27.1 | 47.9 | 7.0 |
3 | 24 | 10/2007 | CC + FSH | P IV | 12/2007, neg.# | Tumor-free | 505.8 | 38.2 | 5.0 |
4 | 23 | 10/2007 | CC + hCG | P IV | 12/2007, neg.# | Tumor-free | 40.5 | 39.9 | 4.8 |
5 | 26 | 11/2007 | CC + FSH + hCG | P III | 02/2008, neg.# | Tumor-free§ | 19.2 | 51.6 | 8.1 |
6 | 30 | 02/2008 | hMG + hCG | P III | 04/2008, neg.# | Tumor-free | 9.8 | 45.6 | 5.2 |
7 | 26 | 11/2008 | FSH + hCG | P III | 01/2009, neg.# | Tumor-free | 38.1 | 45.2 | 6.2 |
8 | 30 | 11/2009 | GnRH-a + hMG + hCG | P III | 01/2010, neg.# | Tumor-free | 56.3 | 37.4 | 4.2 |
9 | 34 | 10/2012 | GnRH-a + FSH + hCG | P III-IV | 12/2012, neg.# | Tumor-free$ | 210.3 | 40.1 | 5.3 |